Xcout Intel
Enhanced Genomics
Enhanced Genomics Ltd. is a functional genomics company headquartered in Cambridge, United Kingdom. The firm utilizes its proprietary 3D multi-omics genomics technology to uncover causal biology behind genetic variation and transform drug target discovery.
Subscribe to see Enhanced Genomics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enhanced Genomics at a glance
Enhanced Genomics is a biotechnology company headquartered in United Kingdom. Its most recent funding round, Series A, raised $19M in September 2025. Xcout tracks 6 named people at Enhanced Genomics, including Dan Turner (Chief Technology Officer).
Enhanced Genomics leadership
- Dan TurnerChief Technology Officer
- Stefan SchoenfelderChief Scientific Advisor
- Catherine MauriceFinance Director
- Peter FraserCo-Founder
- Anne DobréeBoard Director
- Lucy Edwardes-JonesBoard Director
Enhanced Genomics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $19M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Enhanced Genomics competitors
A few of Enhanced Genomics's closest competitors — see the full list of competitors and alternatives →
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
Broken String Biosciences is a biotechnology research company headquartered in Cambridge, England, operating out of Little Chesterford. The company develops advanced platforms dedicated to powering the future of gene editing safety and development.
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Element Genomics was a Duke-founded biotechnology startup established in 2015 to develop computational tools and CRISPR-based approaches for understanding gene regulation. Based in Durham, North Carolina, the company was subsequently acquired by UCB to strengthen its research capabilities.
Get Enhanced Genomics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Enhanced Genomics in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access